Mandate

Vinge is advising Acrinova in its rights issue

Vinge is advising Acrinova AB (publ) in connection with a rights issue which will provide Acrinova with issue proceeds amounting to a maximum of SEK 130 million.

Acrinova is an entrepreneurial-run real estate company operating in southern Sweden with a focus on the Öresund region. Acrinova’s property portfolio is developed through acquisitions, project development and refinement.

Acrinova is listed on Nasdaq First North Growth Market.

Vinge’s team consisted of Linnéa Sellström, Julia Hirschberg and Lorin Arabi.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025